0000903514-19-000008.txt : 20191114
0000903514-19-000008.hdr.sgml : 20191114
20191113174031
ACCESSION NUMBER: 0000903514-19-000008
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190930
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191113
EFFECTIVENESS DATE: 20191114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Svennilson Peter
CENTRAL INDEX KEY: 0001606074
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16412
FILM NUMBER: 191215517
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001606074
XXXXXXXX
09-30-2019
09-30-2019
Svennilson Peter
1700 OWENS STREET
SUITE 500
SAN FRANCISCO
CA
94158
13F HOLDINGS REPORT
028-16412
N
Peter Svennilson
Managing Partner of The Column Group GP, LP and affiliates
4158652050
/s/ Peter Svennilson
San Francisco
CA
11-13-2019
3
8
321765
false
1
0001600420
028-19198
COLUMN GROUP II, LP
2
0001645333
028-19199
Column Group II GP, LP
3
0001182464
028-16413
GOEDDEL DAVID V
INFORMATION TABLE
2
tcg93019.xml
ARCUS BIOSCIENCES INC
COM
03969F109
27941
3070423
SH
OTR
1, 2, 3
0
3070423
0
ARCUS BIOSCIENCES INC
COM
03969F109
4281
470427
SH
OTR
3
0
470427
0
CONSTELLATION PHARMCETICLS I
COM
210373106
16504
2554850
SH
OTR
3
0
2554850
0
CONSTELLATION PHARMCETICLS I
COM
210373106
22318
3454852
SH
OTR
3
0
3454852
0
GRITSTONE ONCOLOGY INC
COM
39868T105
26809
3102934
SH
OTR
1, 2, 3
0
3102934
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
31381
2265758
SH
OTR
1, 2, 3
0
2265758
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
156551
11303333
SH
OTR
3
0
11303333
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
35980
2597816
SH
OTR
3
0
2597816
0